The identification of the base substitution responsible for Ag(x/y) completes the description of the antigen group polymorphisms associated with the apolipoprotein B polypeptide. Surprisingly, all five antigen group polymorphisms alter restriction endonuclease cleavage sites and have associated restriction fragment length polymorphisms, thereby providing a convenient alternative for antigen group phenotyping. (Arteriosclerosis and Thrombosis 1991;ll:379-384) T he antigen group (Ag) polymorphisms are a group of 10 epitopes resulting from five single-amino-acid substitutions scattered along the length of the apolipoprotein (apo) B-100 polypeptide.
T he antigen group (Ag) polymorphisms are a group of 10 epitopes resulting from five single-amino-acid substitutions scattered along the length of the apolipoprotein (apo) B-100 polypeptide. 1 - 6 Human alloantibodies recognizing the first of these 10 epitopes were discovered in 1961 7 in the serum of a patient who had responded to multiple blood transfusions by forming antibodies against allelic variants of the donors' serum proteins. This first epitope, A g^) , was soon shown to be associated with the low density lipoprotein (LDL) fraction of serum. 8 Subsequent studies identified additional epitopes associated with the LDL, and family studies showed these to be closely linked, since crossing over was never observed. 9 As more data were collected, it became possible to group these 10 epitopes into five antithetical pairs, 10 ' 11 that is, pairs of epitopes of which at least one member must be present on the LDL obtained from a single individual. Eventually, the Ag system was shown to be associated with apo B-100, 12 -13 and recently, the underlying nucleotide substitutions responsible for four of the five epitope pairs have been identified and located on the apo B-100 gene.
1 - 6 Here, we report the position and nature of the fifth and final pair, Ag(x/y).
Methods

Genome DNA Source
Human nuclear DNAs were obtained from the white blood cells of 18 individuals as described previously. 14 All these people had been previously Ag phenotyped using a hemoagglutination assay. 15 The five individuals selected for DNA sequencing were donors 4,11,14,15, and 17 listed in Table 3 of Reference 1.
Enzymatic Amplification of DNA
The amplification primers used are summarized in Table 1 . For convenience in subcloning, the amplification primers were designed to contain a restriction site at the 5' end. The amplification reaction 16 was performed in a final volume of 100 yX, containing 1 fig genomic DNA, 0.5 unit Taq polymerase (Promega, Madison, Wis.) in the reaction buffer supplied by the manufacturer, and primers, as described below. For symmetric amplification, 50 pmoles of each primer was used; for asymmetric amplification, 50 pmoles of one primer and 0.5 pmole of the other were employed. To prevent evaporation, 50 /A mineral oil was layered on top, and then the denaturation step was performed at 95°C for 5 minutes, annealing at 55°C for 45 seconds, and extension at 72°C for 2.5 minutes, for the first cycle. Thirty subsequent cycles were performed for 45 seconds at 95°C for denaturation, 45 seconds at 55°C for annealing, and 25 minutes at 72°C for extension. For the last cycle, the extension time was increased to 5 minutes. 17 
Direct Sequencing of Amplified Product
The asymmetrically amplified DNA product was purified by electrophoresis on a 5% polyacrylamide gel and recovered by electroelution. A Sequenase Version 2.0 DNA sequencing kit (United States Biochemicals, Cleveland, Ohio) and deoxyadenosine 5'-a- [ 35 S]thiotriphosphate (Amersham, Arlington Heights, 111.) were used for direct sequencing. The manufacturer's recommended protocol was followed except that priming was performed by incubating the purified DNA and the original low-concentration amplification primer at 95°C for 7 minutes, then cooling to room temperature over a period of 2 minutes, and finally, placing the mixture on ice. After the sequencing reaction, samples were loaded on a 0.4-mm thick 6% poh/acrylamide/7 M urea gel. The gel was run at 75 W for 1.5 hours, fixed in 10% glacial acetic acid/10% methanol (vol/vol, final concentration) for 15 minutes, dried, and exposed to Kodak X-Omat film overnight. 18 
Sequencing via Cloning to pUC19
The symmetrically amplified DNA was digested with the appropriate restriction enzymes and then purified from a 3% NuSieve agarose gel (FMC, Rockland, Me.) by electroelution. Purified DNA fragments were then cloned into pUC19 for DNA sequencing. 10 The pUC19 constructs were primed with either one of the two original amplification primers. Sequencing, electrophoresis, and autoradiography were performed as described above.
Ag(xfy) Phenotyping With Mae / Restriction Endonuclease
The amplified product was purified on 3% NuSieve agarose, and the purified product was digested with Mae I (Boehringer Mannheim, Indianapolis, Ind.) at 45 C C overnight as recommended by the supplier. The digested fragments were loaded onto a 1.2% agarose gel. After 1.5 hours of electrophoresis in buffer at 120 V, the restriction fragments had separated and could be photographed under ultraviolet illumination.
Results
We began our search by selecting five individuals previously Ag haplotyped using human alloantisera and the hemoagglutination assay. 1 Two of these individuals were Ag(x/x), two were Ag(y/y), and one was Ag(x/y). To select regions where the Ag(x/y) polymorphism was likely to be located, we used a table of 61 apparent DNA polymorphisms previously compiled from six published apo B-100 cDNA sequences by Ludwig et al. 19 Thirty-nine of these apparent nucleotide alterations also corresponded to putative amino acid substitutions, and one was an insertion/deletion polymorphism in the signal sequence. Initially, we chose only those eight putative polymorphisms for which the same substitution had been reported by two or more laboratories. Three of these had already been identified with Ag(c/g), Ag(a,/d), and Ag(t/z). 4 Genomic DNA was amplified by the polymerase chain reaction (PCR) 16 and sequenced directly, 17 or cloned into pUC19 and sequenced from the plasmid using the appropriate primer. 18 However, no polymorphisms of any kind were found for the remaining five (Table 2) . Therefore, we turned to the 31 polymorphisms reported only once. Eight of these were previously shown not to be Ag(x/y) by Ma et al. 4 To aid in the selection of putative polymorphic sites likely to be Ag(x/y), we constructed a plot (not shown) of the degree of linkage disequilibrium, expressed as x 2 values, 20 from the insertion/deletion polymorphism located at the 5' end to the four other previously identified Ag sites and to the Xba I and Pvu II restriction fragment length polymorphisms (RFLPs), as a function of known location of these sites on the genomic DNA. Using this plot, the •Locations and frequencies of these putative polymorphic sites on apolipoprotein B cDNA were taken from Reference 19.
tAll five individuals studied showed the same sequences at all of these sites.
degree of linkage disequilibrium to Ag(xZy) 20 was employed to tentatively locate it to the central region of exon 26. Therefore, we amplified and sequenced the genomic DNA from these five individuals and searched for polymorphic sites between amino acids 2,500-2,900. A new polymorphism was identified at amino acid residue 2,712, which matched exactly the pattern expected for Ag(x/y) from the five individuals studied. This polymorphism, not previously reported, is a leucine-to-proline substitution resulting from a single nucleotide change, CTA/CCA, at nucleotide 8,344. Figure 1 is a representative gel showing the DNA sequences in the region near amino acid 2,712 for some of these individuals.
The newly identified site was palindromic for the restriction endonuclease Mae I, which recognizes a sequence of four contiguous nucleotides, CTAG. Flanking Mae I sites occur 108 nucleotides upstream and 488 nucleotides downstream, forming a convenient RFLP. Subsequently, DNA obtained from 18 individuals previously phenotyped by the hemoagglutination assay for Ag(x/y) was amplified by PCR, purified on agarose gels, and cut with Mae I. The match between the RFLP at nucleotide 8,344 and Ag(x/y) was perfect for these 18 individuals (Figure 2 ).
Discussion
The complete description of the Ag polymorphism is shown in Table 3 , including amino acid and nucleotide position and numbering for each site and the corresponding restriction endonuclease that recognizes the site. The locations on the cDNA and on the genomic DNA are shown in Figure 3 . It is remarkable that the five Ag sites are all recognized by restriction endonucleases. The probability that a single base substitution will create a restriction site can be calculated to be about V6. 21 Therefore, the chance that all five Ag sites will correspond to restriction sites is only about {Vi) s =1/243. It is difficult to suggest a plausible reason for this intriguing coincidence; however, it is of considerable practical importance. Currently, the world supply of human alloantisera used for Ag phenotyping is near exhaustion for some of the Ag epitopes, so these restriction sites provide a convenient and timely alternative for Ag phenotyping.
The Ag system has been used to identify more than 15 apo B haplotypes corresponding to at least 15 different apo B alleles. Moreover, the frequencies of these haplotypes have been established in various ethnic groups around the world. 22 The Ag haplotypes should prove to be very useful in anthropological, 22 medical, 23 -26 and forensic 27 studies. The probability of detection of a polymorphism from the sequencing of five individuals (10 alleles) depends on the abundance of the minor form. Thus, if the abundance were 50%, the probability favors detection by 1,023:1 (0. 5 10 ). If the abundance were only 10%, however, the probability of detection through sequencing 10 alleles would be about 2:1 (0.9 10 ). It is interesting to note that of the 40 putative amino acid alterations tabulated by Ludwig et al, 19 22 have now been reexamined. Four of these correspond to Ag(g/c), Ag(a,/d), Ag(t/z), and the insertion/deletion polymorphism in the signal sequence. 28 Of the remaining 18 that have been reexamined by Ma et al 4 and by the authors of this article, none have been confirmed. Two single-amino-acid substitutions not on the original list have also been found; these correspond to Ag(h/i) and Ag(x/y). Thus, only six major amino acid polymorphisms on apo B-100, that is, those having frequencies greater than 1%, have been established at this time. It is to be expected that many rare mutations of apo B-100 exist within the human population, including the rare polymorphism at residue 3,500 that is responsible for familial defective apo B-100. 29 Also, a substantial number of truncated apo B-100 mutants have now been reported, 30 but it seems increasingly unlikely that many additional structural polymorphisms will be found with frequencies of 10% or greater; indeed, the Ag system and the insertion/deletion polymorphism within the signal sequence may include most of these.
The Ag(x-) phenotype, (presumably Ag[y/y]), has been linked to a small but statistically significant elevation in serum cholesterol and serum triglycerides. 31 It is in strong linkage disequilibrium with a silent RFLP at position 2,488, which is recognized by the restriction endonuclease Xba I but is not associated with an amino acid change. Thus, most (>97%) alleles from individuals homozygous for the shorter Xba I RFLP (Xl/Xl individuals) are also Ag(y/ y) 32-35 xhe converse is not true, however, since only about 70% of Ag(y)-containing alleles also contain Xba I XI, and it has been shown that different but overlapping subsets of human apo B alleles are being identified by these two markers. 35 The Xba I (Xl/Xl) polymorphism is even more significantly associated than Ag(x-) with elevated cholesterol and triglyceride levels. 32 -34 It is now recognized that there are at least 14 different commonly found haplotypes of apo B that can be distinguished by different combinations of the five Ag epitopes. 22 Moreover, the relative proportions of these haplotypes have been shown to differ greatly among different populations throughout the world. 22 Since single Ag or RFLP markers would select subsets of these haplotypes, their association with lipid levels might be expected to vary among these different populations. A complete haplotype analysis, allowing the identification and testing of individual alleles, should be more informative; such an analysis has been performed using five RFLPs to identify 15 apo B haplotypes using the Hindi, Pvu II, Xba I, Msp I, and EcoRI RFLPs. In that study, it was found that obesity, serum cholesterol levels, and coronary heart disease were associated with different haplotypes of apo B. 36 From our knowledge of protein structure and its relation to function, it may be logically argued that few amino acid substitutions will be strictly neutral and that some will influence the expression, folding, secretion, function, or catabolism of the protein. The amino acid substitutions resulting in the E2, E3, and E4 polymorphic forms of apo E are an example of common polymorphisms affecting lipoprotein function. 37 With six to choose from, it seems possible that one or more of the common amino acid substitutions of which the Ag system is composed or the insertion/ deletion polymorphism within the signal sequence of apo B may directly influence some aspect of lipoprotein metabolism. At present, however, none of these common mutations have been shown to directly affect lipoprotein metabolism, and only the rare glutamine-to-arginine substitution at residue 3,500 is suspected to be the mutation directly responsible for deficient binding of apo B to the LDL receptor. 38 
